Call for proposals 2020 - H2020 - Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic H2020-SC1-PHE-CORONAVIRUS-2020 Closed!
Objectives
Proposals submitted under this expression of interest are expected to advance the knowledge on 2019-nCoV and its impact on infected persons, with the aim of contributing to an efficient patient management and/or public health preparedness and response. Proposals must be timely, with rapid activation, to enable early and valuable outcomes to be established. For increased impact, proposals may wish to build on promising avenues from previous or ongoing research:
- To contribute to the diagnosis and clinical management of patients infected by 2019-nCoV.
- To contribute to the public health preparedness and response in the context of the ongoing epidemic of 2019-nCoV.
Actions
Considering that this is a newly identified virus, the scope of this expression of interest remains broad and may include topics such as:
- Development of therapeutics, including monoclonal antibodies. As relevant, evidence of regulatory and ethics approvals for the investigational products included in the study(ies) must be presented.
- Development of point of care diagnostics, ensuring rapid evaluation of candidates based on existing technologies, to allow for fast case detection and surveillance.
- Clinical and epidemiological studies, to provide data on epidemiological characteristics such as viral genotype and pathogenicity; clinical information on host susceptibility and host immune responses; risk factors for severe disease; routes of transmission and their relative importance; identification of the animal reservoir; etc.
- Social sciences research, to provide urgently needed answers to social dynamics of the outbreak and the related public health response.
European community funding
The Community provisional funding available for the call for proposals is:
- 10,00 Million EUR (Global Budget)
All the important deadlines
- 12 February 2020 - 6 months ago (Deadline for the presentation of proposals)
Further information about the call
Official webpage of the call
Useful documents
Organisations eligible to participate
Opened to the following bodies or institutes with legal status established in the covered areas:
- Any legal organisation
Covered areas
Bodies or institutes must have their registered legal seat in one of the countries taking part in the Programme which are:
- European Union (EU)
Directorate-Generale responsible
Directorate-General for Research
Related calls for proposals
- Call for proposals for Innovative Medicines Initiative 2014
- Call for proposals and related activities under the 2015 work plan of the Fuel Cells and Hydrogen 2 Joint Undertaking (FCH 2 JU)
- Horizon Prize 2020 - The european capital of innovation award (ICapital)
- 23rd Call for proposals 2020 - Innovative Medicines Initiative 2 Joint Undertaking - H2020-JTI-IMI2
- 22nd Call for proposals 2020 - Innovative Medicines Initiative 2 Joint Undertaking - H2020-JTI-IMI2 - Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities
Explore other programmes
